What is Agenesis Of Corpus Callosum

Agenesis of the corpus callosum (ACC) is a rare congenital brain condition where the band of nerve fibers connecting the left and right hemispheres of the brain fails to develop partially or completely. This structural difference can impact how the two sides of the brain communicate, leading to a wide spectrum of developmental, cognitive, and physical challenges that vary significantly from person to person.

What causes Agenesis of the corpus callosum?

The development of the corpus callosum occurs between the 10th and 20th weeks of pregnancy. Agenesis of the corpus callosum arises when axons (nerve fibers) fail to cross the midline of the brain during this critical window. Causes are diverse and include genetic mutations, chromosomal abnormalities, or prenatal environmental factors, such as maternal infections or exposure to certain substances during fetal development.

How common is Agenesis of the corpus callosum?

The prevalence of Agenesis of the corpus callosum is estimated to be approximately 1 in 4,000 to 1 in 10,000 individuals in the general population. Because some individuals with the condition are asymptomatic or have very mild symptoms, it is likely that many cases remain undiagnosed, making the true prevalence difficult to determine. Currently, our DiseaseMaps.org community includes 304 people with Agenesis of the corpus callosum who are sharing their unique experiences.

What are the primary classifications of the condition?

Clinical experts categorize Agenesis of the corpus callosum based on the extent of the structural absence:

• Complete Agenesis: The entire corpus callosum is absent.


• Partial Agenesis (Hypogenesis): Only a portion of the structure is missing, usually the posterior part.


• Dysgenesis: The structure is present but malformed or thin.

How does Agenesis of the corpus callosum affect the body?

While the impact of Agenesis of the corpus callosum is highly individual, common clinical presentations include:

• Developmental delays in motor milestones (e.g., sitting or walking).


• Difficulties with sensory processing and social cues.


• Language and communication challenges.


• Seizure disorders in some patients.


• Visual or auditory processing impairments.

Next steps

• Consult a pediatric neurologist or geneticist to discuss comprehensive imaging and developmental assessments.


• Connect with the 304 members of the DiseaseMaps.org Agenesis of the corpus callosum community for peer support.


• Consult with early intervention specialists or therapists to address specific developmental needs.

Medical disclaimer: This content is for informational purposes only and does not substitute professional medical advice, diagnosis, or treatment; always seek the guidance of a qualified physician regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Agenesis of the corpus callosum.


• Orphanet: Corpus callosum agenesis.


• OMIM (Online Mendelian Inheritance in Man): Corpus callosum, agenesis of.


• National Organization for Rare Disorders (NORD): Agenesis of the Corpus Callosum.